Northwest Financial Advisors Astrazeneca PLC Transaction History
Northwest Financial Advisors
- $126 Billion
- Q3 2024
A detailed history of Northwest Financial Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Northwest Financial Advisors holds 511 shares of AZN stock, worth $32,601. This represents 0.03% of its overall portfolio holdings.
Number of Shares
511
Previous 1,136
55.02%
Holding current value
$32,601
Previous $88.6 Million
55.09%
% of portfolio
0.03%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.01 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.68 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.38 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.35 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.23 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $198B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...